Ling Dong

6.3k total citations
155 papers, 4.8k citations indexed

About

Ling Dong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ling Dong has authored 155 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 39 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in Ling Dong's work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (14 papers) and MicroRNA in disease regulation (13 papers). Ling Dong is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (14 papers) and MicroRNA in disease regulation (13 papers). Ling Dong collaborates with scholars based in China, United States and Canada. Ling Dong's co-authors include Xizhong Shen, Taotao Liu, Rui Xue, Si Zhang, Shu‐Qiang Weng, Chunhui Deng, Ji‐Min Zhu, Hao Wu, Danying Zhang and Melitta Schachner and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Ling Dong

155 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Dong China 40 2.3k 956 740 559 557 155 4.8k
Carole Nicco France 37 2.2k 0.9× 542 0.6× 612 0.8× 271 0.5× 191 0.3× 107 5.2k
Paolo E. Porporato Italy 40 4.2k 1.8× 2.8k 2.9× 1.0k 1.4× 373 0.7× 495 0.9× 85 7.2k
Dragana Nikitovic Greece 42 2.7k 1.2× 768 0.8× 786 1.1× 296 0.5× 409 0.7× 122 6.0k
Massoud Saidijam Iran 36 2.3k 1.0× 938 1.0× 541 0.7× 359 0.6× 282 0.5× 236 4.7k
Shyng‐Shiou F. Yuan Taiwan 39 3.5k 1.5× 1.2k 1.3× 1.6k 2.1× 263 0.5× 232 0.4× 192 6.3k
Yunjin Jung South Korea 37 2.4k 1.0× 1.2k 1.2× 534 0.7× 422 0.8× 425 0.8× 144 5.6k
Yi Wang China 41 3.1k 1.3× 1.2k 1.3× 1.2k 1.7× 538 1.0× 390 0.7× 266 6.3k
Lin Zhu China 35 2.8k 1.2× 932 1.0× 522 0.7× 287 0.5× 1.1k 1.9× 131 4.4k
Mengxia Li China 31 1.7k 0.7× 449 0.5× 516 0.7× 355 0.6× 198 0.4× 191 3.4k
Mark S. Baker Australia 42 2.7k 1.2× 976 1.0× 606 0.8× 278 0.5× 389 0.7× 156 5.6k

Countries citing papers authored by Ling Dong

Since Specialization
Citations

This map shows the geographic impact of Ling Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Dong more than expected).

Fields of papers citing papers by Ling Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Dong. The network helps show where Ling Dong may publish in the future.

Co-authorship network of co-authors of Ling Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Dong. A scholar is included among the top collaborators of Ling Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Dong. Ling Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Danying, et al.. (2024). Clinical applications and perspectives of circulating tumor DNA in gastric cancer. Cancer Cell International. 24(1). 13–13. 14 indexed citations
2.
Zhang, Yue, et al.. (2024). Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review). International Journal of Oncology. 64(6). 1 indexed citations
3.
Zhang, Guangcong, Kang Song, Jun Du, et al.. (2024). Bismuth-based mesoporous nanoball carrying sorafenib for synergistic photothermal and molecularly-targeted therapy in an orthotopic hepatocellular carcinoma xenograft mouse model. Colloids and Surfaces B Biointerfaces. 245. 114279–114279. 2 indexed citations
4.
Guo, Hongying, et al.. (2023). Increased expression of autophagy‐related gene 5 indicates poor prognosis in patients with hepatocellular carcinoma. Journal of Digestive Diseases. 24(6-7). 399–407. 1 indexed citations
5.
Wang, Fu, Weiqi Xu, Wanqin Zhang, et al.. (2023). Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway. Hepatology International. 18(2). 636–650. 7 indexed citations
6.
Zhang, Guangcong, Xiang‐Nan Yu, Hongying Guo, et al.. (2023). PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism. Cancer Research. 83(4). 521–537. 20 indexed citations
7.
Wang, Fu, Jialei Sun, Guangcong Zhang, et al.. (2022). A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Journal of Translational Medicine. 20(1). 579–579. 2 indexed citations
8.
Wang, Xiang, Jialei Sun, Guangcong Zhang, et al.. (2022). Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 14(33). 37356–37368. 20 indexed citations
9.
Chen, Yanjie, Hao Wu, Ning‐Ping Zhang, et al.. (2022). IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer. Journal of Translational Medicine. 20(1). 68–68. 7 indexed citations
10.
Du, Jun, Zhiyong Liu, Guangcong Zhang, et al.. (2022). Sorafenib-Loaded Cu2−xSe Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma. Nanomaterials. 12(18). 3191–3191. 12 indexed citations
11.
Sun, Jialei, Ning‐Ping Zhang, Guangcong Zhang, et al.. (2021). Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. Journal of Translational Medicine. 19(1). 347–347. 36 indexed citations
12.
Chen, Yanjie, Ling Dong, Taotao Liu, et al.. (2021). Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer. Journal of Translational Medicine. 19(1). 379–379. 22 indexed citations
13.
Yu, Xiang‐Nan, Guangcong Zhang, Hai‐Ning Liu, et al.. (2021). Pre-mRNA processing factor 19 functions in DNA damage repair and radioresistance by modulating cyclin D1 in hepatocellular carcinoma. Molecular Therapy — Nucleic Acids. 27. 390–403. 9 indexed citations
14.
Shi, Xuan, Taotao Liu, Xiang‐Nan Yu, et al.. (2020). microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit. Oncogene. 39(35). 5768–5781. 41 indexed citations
15.
Yu, Xiang‐Nan, Guangcong Zhang, Jialei Sun, et al.. (2020). Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma. Annals of Surgical Oncology. 27(5). 1546–1557. 11 indexed citations
16.
Yu, Xiang‐Nan, Yong Deng, Guangcong Zhang, et al.. (2020). Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model. ACS Applied Materials & Interfaces. 12(15). 17193–17206. 37 indexed citations
17.
Yu, Xiang‐Nan, Hongying Guo, Taotao Liu, et al.. (2019). Upregulated calcium‐binding tyrosine phosphorylation‐regulated protein‐a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma. Journal of Cellular Biochemistry. 121(4). 2938–2949. 6 indexed citations
18.
Cai, Yu‐Dong, Guanqun Huang, Lijie Ma, et al.. (2017). Smurf2, an E3 ubiquitin ligase, interacts with PDE4B and attenuates liver fibrosis through miR-132 mediated CTGF inhibition. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(2). 297–308. 41 indexed citations
19.
Liu, Huikun, Cuiping Zhang, Shuang Zhang, et al.. (2014). Prepregnancy body mass index and weight change on postpartum diabetes risk among gestational diabetes women. Obesity. 22(6). 1560–1567. 60 indexed citations
20.
Dong, Ling. (2003). Tissue Culture and Rapid Propagation of Oenanthe stolonifera. Chih Wu Sheng Li Hsueh T'ung Hsun. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole Nicco Breakdown of academic impact, for papers by Paolo E. Porporato Breakdown of academic impact, for papers by Dragana Nikitovic Breakdown of academic impact, for papers by Massoud Saidijam Breakdown of academic impact, for papers by Shyng‐Shiou F. Yuan Breakdown of academic impact, for papers by Yunjin Jung Breakdown of academic impact, for papers by Yi Wang Breakdown of academic impact, for papers by Lin Zhu Breakdown of academic impact, for papers by Mengxia Li Breakdown of academic impact, for papers by Mark S. Baker
Rankless by CCL
2026